Beta consolidated revenues from operations for FY23 jumpe d by 24% to Rs. 227.tL crores from
Rs. 183’84 crores compared with the same period a year ago. This increase was mainly due to
31% growth in Exports and 24% growth in Own Brand sales. While Apl sales to third parties
grew by 65%.EBITDA excluding Derma impact increased by 28% to Rs.55.92 crores from Rs. 43.7 crores
compared with the year-ago period. While EBITDA margin expanded to 25.04% from 23.g%.
lmprovement in EBITDA was on account of higher sales of branded products and exports along
with the positive impact of backward integration. However, considering the impact on Derma,s
business the consolidated EBITA stood at Rs 53.gg crores.
| Subscribe To Our Free Newsletter |
